Predictmedix Inc. (PMED.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.99 Million CAD | 3.59% |
| 2022 | -2.06 Million CAD | -9.86% |
| 2021 | -1.88 Million CAD | 2.66% |
| 2020 | -1.93 Million CAD | 15.77% |
| 2019 | -2.29 Million CAD | -735.86% |
| 2018 | -274.64 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -258.25 Thousand CAD | 5.69% |
| 2024 Q1 | -273.84 Thousand CAD | 26.57% |
| 2023 Q4 | -372.91 Thousand CAD | 17.02% |
| 2023 FY | -1.99 Million CAD | 3.59% |
| 2023 Q1 | -477.56 Thousand CAD | 48.33% |
| 2023 Q3 | -449.41 Thousand CAD | 35.2% |
| 2023 Q2 | -693.56 Thousand CAD | -45.23% |
| 2022 Q2 | -373 Thousand CAD | -19.83% |
| 2022 FY | -2.06 Million CAD | -9.86% |
| 2022 Q4 | -924.25 Thousand CAD | -101.26% |
| 2022 Q3 | -459.22 Thousand CAD | -23.11% |
| 2022 Q1 | -311.26 Thousand CAD | 49.98% |
| 2021 FY | -1.88 Million CAD | 2.66% |
| 2021 Q2 | -382.58 Thousand CAD | 7.63% |
| 2021 Q1 | -414.18 Thousand CAD | 34.51% |
| 2021 Q3 | -463.11 Thousand CAD | -21.05% |
| 2021 Q4 | -622.28 Thousand CAD | -34.37% |
| 2020 FY | -1.93 Million CAD | 15.77% |
| 2020 Q1 | 17.88 Thousand CAD | 105.55% |
| 2020 Q3 | -493.84 Thousand CAD | -4.35% |
| 2020 Q2 | -473.26 Thousand CAD | -2745.58% |
| 2020 Q4 | -632.47 Thousand CAD | -28.07% |
| 2019 Q4 | -322.29 Thousand CAD | 80.79% |
| 2019 Q3 | -1.67 Million CAD | -946.9% |
| 2019 Q1 | -116.49 Thousand CAD | -39.67% |
| 2019 FY | -2.29 Million CAD | -735.86% |
| 2019 Q2 | -160.25 Thousand CAD | -37.56% |
| 2018 Q3 | -111.83 Thousand CAD | -271.74% |
| 2018 FY | -274.64 Thousand CAD | 0.0% |
| 2018 Q4 | -83.4 Thousand CAD | 25.42% |
| 2018 Q2 | -30.08 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aquarius Surgical Technologies Inc. | -757.66 Thousand CAD | -163.108% |
| Cannabix Technologies Inc. | -3.12 Million CAD | 36.242% |